BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12908511)

  • 1. Immunomodulation with antibodies: clinical application in ovarian cancer and other malignancies.
    Nicodemus CF; Schultes BC; Hamilton BL
    Expert Rev Vaccines; 2002 Jun; 1(1):35-48. PubMed ID: 12908511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological therapy of ovarian cancer: current directions.
    Bookman MA
    Semin Oncol; 1998 Jun; 25(3):381-96. PubMed ID: 9633851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current approaches in ovarian cancer vaccines.
    Reinartz S; Wagner U
    Minerva Ginecol; 2004 Dec; 56(6):515-27. PubMed ID: 15729204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune therapy for ovarian cancer: promise and pitfalls.
    Thibodeaux SR; Curiel TJ
    Int Rev Immunol; 2011; 30(2-3):102-19. PubMed ID: 21557637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer immunotherapy.
    Baxevanis CN; Perez SA; Papamichail M
    Crit Rev Clin Lab Sci; 2009; 46(4):167-89. PubMed ID: 19650714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immuno-therapeutic study of anti-idiotype minibody (single chain Fv-CH3) on ovarian carcinoma bearing mice].
    Li Y; Chang XH; Cui H; Yang WL; Feng J; Wei LH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):451-6. PubMed ID: 12974094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic approaches to ovarian cancer treatment.
    Sabbatini P; Odunsi K
    J Clin Oncol; 2007 Jul; 25(20):2884-93. PubMed ID: 17617519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody therapy of ovarian cancer.
    Nicodemus CF; Berek JS
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):87-96. PubMed ID: 15757441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current advances in cancer immunotherapy (author's transl)].
    Belpomme D; Marty M; Gisselbrecht C; Mignot L; Pujade-Lauraine E
    Sem Hop; 1981 Oct 8-15; 57(37-38):1547-56. PubMed ID: 6270825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biologic therapy and epithelial ovarian cancer].
    Porpiglia M; Vicelli R; Durando A; Fracchioli S; Puopolo M; Katsaros D; Bellino R; Benedetto C
    Minerva Ginecol; 2004 Feb; 56(1):91-104. PubMed ID: 14973413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current advances in cancer immunotherapy (author's therapy)].
    Belpomme D; Marty M; Gisselbrecht C; Mignot L; Pujade-Lauraine E
    Pathol Biol (Paris); 1981 Mar; 29(3):179-88. PubMed ID: 7017560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harnessing the immune system for ovarian cancer therapy.
    Odunsi K; Sabbatini P
    Am J Reprod Immunol; 2008 Jan; 59(1):62-74. PubMed ID: 18154597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer vaccines: preclinical studies and novel strategies.
    Palena C; Abrams SI; Schlom J; Hodge JW
    Adv Cancer Res; 2006; 95():115-45. PubMed ID: 16860657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy for ovarian cancer: recent advances and perspectives.
    Zsiros E; Tanyi J; Balint K; Kandalaft LE
    Curr Opin Oncol; 2014 Sep; 26(5):492-500. PubMed ID: 25036883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor antibodies in ovarian cancer.
    Luborsky JL; Barua A; Shatavi SV; Kebede T; Abramowicz J; Rotmensch J
    Am J Reprod Immunol; 2005 Aug; 54(2):55-62. PubMed ID: 16105096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T cells in ovarian cancer: biology and therapeutic potential.
    Barnett B; Kryczek I; Cheng P; Zou W; Curiel TJ
    Am J Reprod Immunol; 2005 Dec; 54(6):369-77. PubMed ID: 16305662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
    Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A
    Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel therapeutic agents in ovarian cancer.
    Agarwal R; Linch M; Kaye SB
    Eur J Surg Oncol; 2006 Oct; 32(8):875-86. PubMed ID: 16704916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
    Ozols RF; Herbst RS; Colson YL; Gralow J; Bonner J; Curran WJ; Eisenberg BL; Ganz PA; Kramer BS; Kris MG; Markman M; Mayer RJ; Raghavan D; Reaman GH; Sawaya R; Schilsky RL; Schuchter LM; Sweetenham JW; Vahdat LT; Winn RJ;
    J Clin Oncol; 2007 Jan; 25(1):146-62. PubMed ID: 17158528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.